Marianne Ølholm

Senior Vice President, Novo Nordisk

Marianne Ølholm is Senior Vice President at Novo Nordisk, where she is responsible for the planning and execution of the company’s global trial portfolio across all clinical development phases.

Over the past 25 years, Marianne has held a variety of leadership roles in Denmark and internationally, including establishing Novo Nordisk’s research center in Beijing. Her experience spans leading projects in the metabolic disease development portfolio and overseeing the R&D of devices and delivery solutions across the company’s portfolio.

Marianne holds a PhD within in vivo pharmacology and a DMSc from the University of Copenhagen.